ããŒã¿ãµã€ãšã³ãã£ã¹ããšããŠãããŒã¿ãåæããŠè§£éã§ããããã«ããããšã¯ç§ãã¡ã®è²¬ä»»ã§ãã ãããŠãç§ãã¡ã¯ covid-19 ã«é¢é£ããããŒã¿ã®åæçµæãéåžžã«æžå¿µããŠããŸããã æããªã¹ã¯ã«ãããããŠããã®ã¯ãé«éœ¢è
ãäœæåŸè
ãªã©æã匱ãç«å Žã«ãã人ã
ã§ãããç
æ°ã®è延ãšåœ±é¿ãå¶åŸ¡ããã«ã¯ãç§ãã¡å
šå¡ãè¡åãå€ããå¿
èŠããããŸãã 培åºçãã€å®æçã«æãæŽãã人混ã¿ãé¿ããã€ãã³ããäžæ¢ããé¡ã«è§Šããªãããã«ããŠãã ããã ãã®èšäºã§ã¯ããªãç§ãã¡ãå¿é
ããã®ãããããŠãªãããªããå¿é
ããå¿
èŠãããã®ãââã説æããŸãã éèŠãªæ
å ±ã®æŠèŠã«ã€ããŠã¯ãEthan Alley ã®æçš¿ãåç
§ããŠãã ããã
å 容ïŒ
æ©èœããå»çã·ã¹ãã ãå¿ èŠã§ã ã€ã³ãã«ãšã³ã¶ã®ãããªãã®ã§ã¯ãããŸãã ããããã¯ã«ãªãããèœã¡çããŠããšããã¢ãããŒãã¯åœ¹ã«ç«ããªã ããã¯ããªãã ãã®åé¡ã§ã¯ãããŸãã æ²ç·ãå¹³ãã«ããå¿ èŠããã 瀟äŒã®å¯Ÿå¿ãéèŠ ç±³åœã«äœãç§ãã¡ã«ã¯ååãªæ å ±ããããŸããã ãŸãšã
1. æ©èœããå»çã·ã¹ãã ãå¿ èŠã§ãã
ã»ãã® 2 幎åãç§ãã¡ã®äžäºº (ã¬ã€ãã§ã«) ãææçã«ããããè³ã«åœ±é¿ãåãŒããææè ã® XNUMX åã® XNUMX ãæ»äº¡ããããã«ææè ã® XNUMX 人㫠XNUMX 人ãèªç¥é害ãåŒãèµ·ãããŸããã çåè ã®å€ãã¯æ°žä¹ çãªèŽèŠé害ãšèŠèŠé害ã«èŠããã§ããŸãã ç é¢ã«çããŸã§ã«ã¬ã€ãã§ã«ã¯é¯ä¹±ç¶æ ã«ãªã£ãŠããŸããã 圌女ã¯å¹žéã«ãã¿ã€ã ãªãŒãªå»çã蚺æãæ²»çãåããããšãã§ããŸããã ãã®åºæ¥äºã®çŽåã«ã圌女ã®æ°åã¯çŽ æŽããããææ¥å€æ¥ãžã®è¿ éãªã¢ã¯ã»ã¹ã«ããã圌女ã®åœã¯æãããå¯èœæ§ããããŸãã
ããã§ãæ°åã³ãããŠã€ã«ã¹ææçïŒcovid-19ïŒãšãã¬ã€ãã§ã«ã®ãããªç¶æ³ã«ãã人ã ã«ä»åŸæ°é±éãæ°ãæã§äœãèµ·ãããã«ã€ããŠè©±ããŸãããã 確èªããã covid-19 ææçäŸæ°ã¯ 3 ïœ 6 æ¥ããšã« 100 åã«ãªããŸãã ãã®æéã 19 æ¥ãšãããšã16 é±éåŸã«ã¯ææè æ°ã¯ 6 åã«å¢å ããŸã (å®éããã¹ãŠã¯ããã»ã©åçŽã§ã¯ãããŸããããæè¡çãªè©³çŽ°ã«æ°ãåãããªãããã«ããŸããã)ã ææè ã®XNUMX人ã«XNUMX人ã¯é·æïŒæ°é±éïŒã®å ¥é¢ãå¿ èŠãšãªãããããã®æ£è ã®ã»ãšãã©ã¯é žçŽ ãå¿ èŠãšããŸãã ãŠã€ã«ã¹ã®è延ã¯å§ãŸã£ãã°ããã§ãããäžéšã®å°åã§ã¯ãã§ã«ç é¢ãæ··éããŠããã人ã ãïŒæ°åã³ãããŠã€ã«ã¹ææçã«éããããŸããŸãªçç¶ã§ïŒå¿ èŠãªæ²»çãåããããŸããã ããšãã°ãã€ã¿ãªã¢ã§ã¯ããããXNUMXé±éåã«åœå±ããã¹ãŠåé¡ãªããšçºè¡šããããçŸåšã¯XNUMXäžäººãéé¢ãããŠããïŒè¿œèšïŒå ±éã®XNUMXæéåŸã«ã¯åœå šäœãééãããïŒã æŒãå¯ããæ£è ã«å¯ŸåŠããããã«ã次ã®ãããªãã³ããèšçœ®ãããŠããŸãã
ã€ã¿ãªã¢ã§æã被害ã倧ããã£ãå°åã®å°åå±ââæ©ã»ã³ã¿ãŒæé·ã§ããã¢ã³ãããªã»ãã»ã³ãã£å士ã¯ããå»äžãæè¡å®€ããªãããªããŒã·ã§ã³å®€ã«éäžæ²»ç宀ãèšçœ®ããªããã°ãªããªãâŠãã³ãã«ãã£ã¢å·ã¯åŽ©å£ã«åãã£ãŠãããã
2. ã€ã³ãã«ãšã³ã¶ã®ãããªãã®ã§ã¯ãããŸããã
ã€ã³ãã«ãšã³ã¶ã®æ»äº¡çã¯çŽ0,1ïŒ
ã§ãã ããŒããŒã倧åŠææçãã€ããã¯ã¹ã»ã³ã¿ãŒæé·ã®ããŒã¯ã»ãªãã·ããæ°ã¯ããèªãã
ç§ãã¡ã®è³ã¯ãææè æ°ã®ææ°é¢æ°çãªå¢å ãçŽæçã«èªèããããã«ã¯èšèšãããŠããŸããã ãããã£ãŠãç§ãã¡ã¯ç§åŠè ãšããŠãçŽæã«é Œããã«åæãè¡ã£ãŠãããŸãã
ã€ã³ãã«ãšã³ã¶ã«ææãã人 1,3 人ã¯ãå¹³åã㊠0 人ã«ææãããŸãã ãã®ã€ã³ãžã±ãŒã¿ãŒã¯ R0 ãšåŒã°ããŸãã R1 ã 1 æªæºã®å Žåãææã®æ¡å€§ã¯æ¢ãŸããŸããã19 ãã倧ããå Žåãææã¯æ¡å€§ãç¶ããŸãã äžåœåœå€ã® covid-0 ã®å ŽåãR2 㯠3 ïœ 20 ã§ãã éãã¯ãããã«èŠãããããããŸããããææã 0 åãå埩ãããåŸã®ææè æ°ã¯ãR1,3=146 ã®å Žå㯠0 人ãR2,5=36 ïœ XNUMX äžäººã«ãªããŸãã ãããã¯åçŽåãããèšç®ã§ãããåççãªèª¬æãšããŠåœ¹ç«ã¡ãŸãã 芪æ covid-19ãšã€ã³ãã«ãšã³ã¶ã®éãã
R0 ã¯ç æ°ã®åºæ¬çãªç¹åŸŽã§ã¯ãªãããšã«æ³šæããŠãã ããã ãã®å²åã¯[ç æ°ã«å¯Ÿãã]åå¿ã«å€§ããäŸåããŠãããæéã®çµéãšãšãã«å€åããå¯èœæ§ããããŸã2ã ããšãã°ãäžåœã§ã¯ covid-0 ã® R19 ãæ¥éã«æžå°ããŠãããçŸåšã¯ 1 ã«éããŠããŸãã ã©ãããŠãããªããšãå¯èœãªã®ã§ããããïŒ å€ãã®å·šå€§éœåžãå®å šã«å°éããé±ã«XNUMXäžäººãæ€æ»ã§ãã蚺ææé ãéçºãããªã©ãç±³åœã®ãããªåœã§ã¯æ³åãã«ããæªçœ®ãå°å ¥ããããšã«ãã£ãŠã
ãœãŒã·ã£ã« ã¡ãã£ã¢ (ã€ãŒãã³ ãã¹ã¯ã®ãããªäººæ°ã®ã¢ã«ãŠã³ããå«ã) ã§ã¯ãããžã¹ãã£ãã¯ãªæé·ãšææ°é¢æ°çãªæé·ã®éããç解ãããŠããªãããšããããããŸãã å®éã®ããžã¹ãã£ãã¯æé·ã¯æµè¡æ²ç·ã® S ååã«å¯Ÿå¿ããŸãã ãã¡ãããææè æ°ã¯å°çã®äººå£èŠæš¡ã«ãã£ãŠåžžã«å¶éããããããææ°é¢æ°çãªå¢å ãç¡éã«ç¶ãããšã¯ã§ããŸããã çµæãšããŠãçºççã¯æžå°ããæé·ç察æéã® S ååæ²ç· (ã·ã°ã¢ã€ã) ãåŸãããŸãã ãã ãããã®åæžã¯éæ³ã®ããã«ã§ã¯ãªããç¹å®ã®æ¹æ³ã§å®çŸãããŸãã äž»ãªæ¹æ³:
- 倧èŠæš¡ãã€å¹æçãªåœæ°ã®åå¿ã
- ç æ°ã«ãªã人ã®å²åãéåžžã«å€§ãããããç æ°ã§ãªã人ã®æ°ãå°ãªããããããææãããã«æ¡å€§ããŸãã
ãããã£ãŠããã³ãããã¯ããå¶åŸ¡ãããæ¹æ³ãšããŠããžã¹ãã£ãã¯æé·æ²ç·ã«èšåããã®ã¯è³¢æã§ã¯ãããŸããã
å°å瀟äŒãžã® covid-19 ã®åœ±é¿ãçŽèŠ³çã«ç解ããã®ãé£ãããã 11 ã€ã®åŽé¢ã¯ãææããå ¥é¢ãŸã§ã«éåžžã«å€§ããªé ããããããšã§ã (éåžžã¯çŽ 5 æ¥)ã ããã¯ããã»ã©é·ãæéã§ã¯ãªãããã«æãããããããŸãããããã®ãããªæéã¯ããã¹ãŠã®ç åºãåãŸããŸã§ã«ãææè æ°ã¯å ¥é¢è æ°ã®10ãXNUMXåã«ãªãããšãæå³ããŸãã
æææ¡å€§ã«å¯Ÿããæ°åã®åœ±é¿ã®åæã®å
åãããã€ãããããšã«æ³šæããŠãã ããã åºçäž
3. ããããã¯ã«ãªããªãã§ãèœã¡çããŠãã ããããšããã¢ãããŒãã¯åœ¹ã«ç«ã¡ãŸããã
ãœãŒã·ã£ã«ã¡ãã£ã¢ã§ã¯ãæžå¿µã®çç±ãææãã人ã«å¯ŸããŠãããããã¯ã«ãªããªãã§ããšããèœã¡çããŠããšèšãããããšããããããŸãã ããã¯æ§ããã«èšã£ãŠãç¡é§ã§ãã ãããã¯ã蚱容ã§ããåå¿ã§ãããšã¯èª°ãèšã£ãŠããŸããã ããããäžéšã®ãµãŒã¯ã«ã§ã¯ãå·éãä¿ã€ãããšãäžè¬çãªåå¿ã§ããã®ã«ã¯çç±ããããŸãïŒãã ãããã®ãããªããšã远跡ããã®ãä»äºã§ããç«åŠè ã®éã§ã¯ããã§ã¯ãããŸããïŒã ããããããå¹³éãä¿ã€ãããšã§ã人ã¯äœãããªãèªåãããå¿«é©ã«æããããéŠã®ãªãé¶ã®ããã«èµ°ãåã£ãŠãããšèªèãã人ã«å¯ŸããŠåªè¶æãæããããšãã§ããããã«ãªãã®ãããããŸããã
ãããããå·éããä¿ã€ãããšã¯ãé©åãªæºåã察å¿ãç°¡åã«åŠšããå¯èœæ§ããããŸãã çŸç çµ±èšãçŸåšç±³åœã§èŠãããã¬ãã«ã«éãããŸã§ã«ãäžåœã¯æ°åäžäººã®åœæ°ãéé¢ãã8ã€ã®ç é¢ã建èšããŠããã ã€ã¿ãªã¢ã¯ããŸãã«ãé·ãåŸ ã¡ãããããã1492äžäººãéé¢ãããŠããã«ãããããããä»æ¥ïŒ133æ16æ¥ïŒã ãã§2人ã®æ°èŠææè ãš3人ã®æ°ããªæ»äº¡è ãå ±åããã ç§ãã¡ãå ¥æå¯èœãªæè¯ã®æ å ±ã«åºã¥ããšãã»ãã® XNUMX ïœ XNUMX é±éåãã€ã¿ãªã¢ã®çŸç çµ±èšã¯çŸåšã®ç±³åœããã³è±åœãšåãã¬ãã«ã§ããã
çŸæ®µéã§ã¯ covid-19 ã«é¢ããç¥èãã»ãšãã©ãªãããšã«ã泚æãã ããã ãã®è延çãæ»äº¡çãã©ãããããªã®ããå°è¡šã§ã©ã®ãããã®æéåç¶ããã®ããæããæ¡ä»¶äžã§ãçã延ã³ãŠè延ããã®ãã©ãããç§ãã¡ã¯å®éã«ã¯ç¥ããŸããã ç§ãã¡ãæã£ãŠããã®ã¯ãåéã§ããæè¯ã®æ
å ±ã«åºã¥ãæšæž¬ã ãã§ãã ãããŠãã»ãšãã©ã®æ
å ±ã¯äžåœããäžåœèªã§çºä¿¡ãããŠããããšãå¿ããªãã§ãã ããã çŸåšãäžåœã®çµéšãç解ããããã®æè¯ã®æ
å ±æºã¯å ±åæžã§ããã
äžççãªãã³ãããã¯ã¯èµ·ãããªããããã ãã ãšããäžç¢ºå®æ§ãåã«ããŠã å€åãå»çå¶åºŠã厩å£ãããªãéããäœãããªãããšã¯æ£ãã察å¿ãšã¯æããŸããã ããã¯éåžžã«å±éºã§ãããã·ãã¥ã¬ãŒããããã·ããªãªã§ã¯æé©ãšã¯èšããŸããã ãŸããã€ã¿ãªã¢ãäžåœã®ãããªåœãæ£åœãªçç±ãªãçµæžã®å€§éšåãäºå®äžééããå¯èœæ§ã¯äœãããã«æãããã ãŸããç¡çã¯ãå»çã·ã¹ãã ãç¶æ³ã«å¯Ÿå¿ã§ããªãææå°åã§èŠãããå®éã®åœ±é¿ãšãççŸããŠããŸãïŒããšãã°ãã€ã¿ãªã¢ã§ã¯ãæ£è
ã®äºåããªã¢ãŒãžã®ããã«462ã®ãã³ãã䜿çšãããŠããŸãããäŸç¶ãšããŠãã³ãã®èšçœ®ãå¿
èŠã§ãïŒ
代ããã«ãææ ®æ·±ãè³¢æãªå¯Ÿå¿ã¯ãææã®æ¡å€§ãé²ãããã«å°é家ãæšå¥šãã次ã®æé ã«åŸãããšã§ãã
- 倧èŠæš¡ãªã€ãã³ãã人ã®å¯éãé¿ãã
- ã€ãã³ãããã£ã³ã»ã«ãã
- å¯èœãªéãåšå® å€å
- åž°å® æãå€åºæãªã©å®¶ã®å€ã§éãããšãã¯æãæŽããŸããã
- ç¹ã«å€åºäžã¯é¡ã«è§Šããªãããã«ããŠãã ããïŒããã¯ç°¡åã§ã¯ãããŸããïŒïŒã
- è¡šé¢ãšæ¢±å æãæ¶æ¯ããŸãïŒãŠã€ã«ã¹ã¯è¡šé¢äžã§æé· 9 æ¥é掻æ§ãç¶æããå¯èœæ§ããããŸããã確å®ãªããšã¯ããã£ãŠããŸããïŒã
4. ããã¯ããªãã ãã®åé¡ã§ã¯ãããŸãã
50 æ³æªæºã§ãå ç«åã®äœäžãå¿è¡ç®¡çŸæ£ãéå»ã®å«ç æŽãæ ¢æ§çŸæ£ãªã©ã®å±éºå åããªãå Žåã¯ãæ°åã³ãããŠã€ã«ã¹ææçã«ãã£ãŠæ»äº¡ããå¯èœæ§ã¯äœããšããªã確信ã§ââããŸãã ããããèµ·ãã£ãŠããããšã«å¯Ÿããããªãã®åå¿ã¯äŸç¶ãšããŠéåžžã«éèŠã§ãã ããªããä»ã®äººãšåãããã«ææããå¯èœæ§ããããããææãããšããŠããä»ã®äººã«ææãããå¯èœæ§ãåãããããããŸãã å¹³åããŠãåææè 㯠19 人以äžã«ææãããçç¶ãçŸããåã«ææåãçºæ®ããŸãã ããªãã«å€§åãªäž¡èŠªãç¥ç¶æ¯ãããŠã圌ããšæéãéããã€ããã§ããã®ã«ã圌ããæ°åã³ãããŠã€ã«ã¹ã«ææããã責任ãèªåã«ããããšãå€æããå Žåãããã¯å€§ããªè² æ ãšãªãã§ãããã
50æ³ä»¥äžã®äººãšé¢ããããšããªããŠããæ
¢æ§çŸæ£ãæ±ããååãç¥äººã¯æã£ãŠãã以äžã«å€ãã¯ãã§ãã
ãããŠãã¡ãããç§ãã¡ã¯ããªãã®èº«è¿ãªç°å¢ã«ãã人ã
ã ãã«ã€ããŠè©±ããŠããã®ã§ã¯ãããŸããã ããã¯éåžžã«éèŠãªå«ççåé¡ã§ãã ãŠã€ã«ã¹ã®è延ãšéãããã«ã§ããéãã®ããšããããã¹ãŠã®äººããå°å瀟äŒå
šäœã®ææçãäžããã®ã«åœ¹ç«ã¡ãŸãã ãŒã€ããã»ãã¥ãã§ã¯ããæžããããã«
ç§ãã¡ã¯å人çã«å±éºãæããŠããããã§ã¯ãªããå šå¡ã®ãªã¹ã¯ã軜æžããããã«åããã¹ãã§ãã ç§ãã¡ãåããªããã°ãªããªãã®ã¯ãç§ãã¡ãã³ã³ãããŒã«ã§ããªãçµæ«ã®ã·ããªãªã«çŽé¢ããŠããããã§ã¯ãªãã瀟äŒãšããŠçŽé¢ãããã®ãªã¹ã¯ã®ããããåŽé¢ãå€ããããšãã§ããããã§ãã ããã§ããé£äººãããªãã«æºåãå¿ èŠãšããŠããã®ã§ãããªãã¯æºåãããªããã°ãªããŸãããç¹ã«å¹Žé ã®é£äººãç é¢ã§åãé£äººãæ ¢æ§çŸæ£ãæ±ããŠããé£äººããããŠæºåããæ段ãæéããªããããããªãé£äººã§ãã
ããã¯ç§ãã¡å人ã«åœ±é¿ãäžããŸããã fast.ai ã«é¢ããŠç§ãã¡ããããŸã§ã«äœæããæ倧ãã€æãéèŠãªã³ãŒã¹ã¯ãé·å¹Žã®åãçµã¿ã®é倧æã§ããã4 é±é以å ã«ãµã³ãã©ã³ã·ã¹ã³å€§åŠã§éå§ãããäºå®ã§ããã å é±ã®æ°Žææ¥ïŒ3æXNUMXæ¥ïŒãç§ãã¡ã¯ãã¹ãŠããªã³ã©ã€ã³ã«ç§»è¡ããããšã決å®ããŸããã ç§ãã¡ã¯ããªã³ã©ã€ã³ã«ç§»è¡ããæåã®å€§èŠæš¡ã³ãŒã¹ã® XNUMX ã€ã§ããã ãªããããªããšãããã®ã§ããããïŒ ãªããªãããã®ã³ãŒã¹ãå®è¡ãããšãæ°é±éã«ããã£ãŠæ°çŸäººãå¯éããã空éã«éãŸãããšãéæ¥çã«å¥šå±ããããšã«ãªãããšã«ãå é±åãã«æ°ã¥ããããã§ãã æããã£ãŠã¯ãããªãããšã¯ãéããã空éã«äººã ãéãŸãããšã§ããããããé¿ããã®ãç§ãã¡ã®é埳ç矩åã§ããã æ¯å¹ŽåŠçãã¡ãšååããã®ã¯ç§ãã¡ã«ãšã£ãŠæ倧ã®åã³ã§ãããæãçç£çãªææã ã£ãããããã®æ±ºæã¯å°é£ã§ããã ãããŠãæµ·å€ããé£è¡æ©ã§æ¥ãããšããŠããåŠçãããŸããããç§ãã¡ã¯åœŒãã倱æãããããããŸããã§ããXNUMXã
ããããããããããã°ãç§ãã¡ã®å°å瀟äŒã§ã®ç æ°ã®è延ã«è²¢ç®ããããšã«ãªããããç§ãã¡ã¯èªåãã¡ãæ£ããããšãããŠããããšãç¥ã£ãŠããŸãã4ã
5. æ²ç·ãããå¹³åŠã«ããå¿ èŠããããŸã
åžäžææçãäžããããšãã§ããã°ãç é¢ã¯æµå ¥ããææè ãšéåžžã®æ£è ã®äž¡æ¹ã«å¯ŸåŠã§ããããã«ãªããããããã¯éåžžã«éèŠã§ãã 以äžã®å³ã¯ãããæ確ã«ç€ºããŠããŸãã
å åœæ°ä¿å¥ITã³ãŒãã£ããŒã¿ãŒã®ãã¡ã«ã¶ãã»ã¢ã¹ã¿ã·ã£ãªæ°ã¯æ¬¡ã®ããã«èª¬æããŠããŸãããéæ è¡è ããã³éæ¥è§Šææè ã®æ°ããªææè ãæ¯æ¥ç¹å®ãããŠãããããã¯æ€æ»ã®é ãã«ããæ°·å±±ã®äžè§ã«éããªãããšãããã£ãŠããŸãã ããã¯ãä»åŸ XNUMX é±éã§ææè æ°ãççºçã«å¢å ããããšãæå³ããŸã...å°å瀟äŒã§ã®ççºçãªæææ¡å€§ãæããããšããããšã¯ãå®¶å šäœãçããŠãããšãã«ç«ã®ç²ãæ¶ãããšã«éäžãããããªãã®ã§ãã ãããèµ·ãã£ãå Žåãç§ãã¡ã¯ç·©åçã«åãæ¿ããå¿ èŠããããæææ¡å€§ãé ãããå ¬è¡è¡çãžã®æ倧ã®åœ±é¿ã軜æžããããã®ä¿è·æªçœ®ãè¬ããå¿ èŠããããŸããã æææ¡å€§çãååã«äœãæããããšãã§ããã°ãç é¢ã¯å¯ŸåŠããããšãã§ããæ£è ã¯å¿ èŠãªã±ã¢ãåããããšãã§ããŸãã ããããªããšãå ¥é¢ãå¿ èŠãªäººãå ¥é¢ã§ããªããªããŸãã
ã«ãã
ç±³åœã«ã¯äººå£ 2,8 人ãããçŽ 1000 ã®ç
é¢ãããããããŸãã 人å£ã 330 å 1 äžäººã§ããããããããæ°ã¯çŽ 65 äžåºãšãªãããã® 330% ãæä¹
çã«å æãããŠããŸãã ãããã£ãŠãåèš 10 ã®ããããå©çšå¯èœã§ã (ããããå£ç¯æ§ã€ã³ãã«ãšã³ã¶ãªã©ã®ããã§ããå°ãå°ãªãã§ããã)ã ã€ã¿ãªã¢ã®çµéšãåãå
¥ããŠãçäŸã®çŽ 19% ãå
¥é¢ãå¿
èŠãšããã»ã©é節ã§ãããšä»®å®ããŸãããã ãããŠãå
¥é¢ã¯ãã°ãã°æ°é±éç¶ãããšãç§ãã¡ã¯èŠããŠããŸããã€ãŸããæ°åã³ãããŠã€ã«ã¹ææçæ£è
ã®ãããããã¯éåžžã«ãã£ãããšè§£æŸãããããšã«ãªããŸãã ãããã®æšå®ã«ãããšã8 æ 2 æ¥ãŸã§ã«ãã¹ãŠã®ç
åºãåãŸãèŠèŸŒã¿ã§ãã ãããŠåæã«ããããã®ãããããŠã€ã«ã¹æ§çŸæ£ã®æ£è
ãå容ããã®ã«é©ããŠãããã©ãããèæ
®ããŠããŸããã éçè
ã®å²åã 6 åééã£ãŠãããšãããšãç
é¢ã®é£œåæé㯠XNUMX æ¥ã ãäžæ¹åã«ãããããšã«ãªããŸãã ãããã¯ã©ãããä»ã®çç±ã§å Žæã®éèŠãå¢å ããããšãæ³å®ããŠããŸããããããã¯çãããä»®å®ã®ããã«æããŸãã å»çå¶åºŠãžã®éŒè¿«ãšåŠæ¹è¬ã®äžè¶³ã«ãããæ
¢æ§çŸæ£ãæã€äººã
ã¯æ²»çãå
¥é¢ãå¿
èŠãšããç¶æ³ã«é¥ãå¯èœæ§ããããŸãã
6. åœæ°ã®å¯Ÿå¿ã«é¢ããäºé ã
ãã§ã«è°è«ããããã«ããããã®æ°åã«ã€ããŠã¯ç¢ºå®æ§ã¯ãããŸãããäžåœã¯ãã§ã«ã極端ãªæªçœ®ã«ãã£ãŠç
æ°ã®è延ãæå¶ã§ããããšãå®èšŒããŠããŸãã ãã XNUMX ã€ã®åªããäŸã¯ãããã ã§ããããã§ã¯ããšããããå
šåœèŠæš¡ã®åºåãã£ã³ããŒã³ (å¿ã«æ®ãæã!) ãæ¥éã«åœæ°ãåå¡ããå¿
èŠãªè¡åå€å®¹ããããããŸããã
ãããã®èšç®ã¯ä»®èª¬ã§ã¯ãªãã1918 幎ã®ã€ã³ãã«ãšã³ã¶ã®ãã³ãããã¯äžã«ãã¹ãŠããã¹ããããŸãããç±³åœã§ã¯ 200 ã€ã®éœåžã®åå¿ããŸã£ããç°ãªããŸããããã£ã©ãã«ãã£ã¢ã§ã¯ãæŠè²»ãéããããã« XNUMX äžäººãåå ããŠå€§èŠæš¡ãªãã¬ãŒããéå¬ãããŸããã ããããã»ã³ãã«ã€ã¹åžã¯ãŠã€ã«ã¹ã®è延ãæžããããã«ç€ŸäŒçæ¥è§Šãæå°éã«æãããã¹ãŠã®å
Œ
±ã€ãã³ãããã£ã³ã»ã«ããã ããŒã¿ã«ããåéœåžã®æ»è
æ°ã¯ãããªæã
ãã£ã©ãã«ãã£ã¢ã®ç¶æ³ã¯æ¥µããŠæ²æšãªãã®ãšãªã£ãŠããã
1幎ã®H1N2009ãã³ãããã¯æã«çŸç 管çäºé²ã»ã³ã¿ãŒã®ãšã°ãŒã¯ãã£ããã£ã¬ã¯ã¿ãŒãåãããªãã£ãŒãã»ãããµãŒæ°ã¯ãç±³åœã§ã¯ãææã®ãªã¹ã¯ãšèªåãšå®¶æãå®ãèœåã¯ãåå ¥ãªã©ã®èŠå ã«å·Šå³ãããããšè¿°ã¹ãŠããã ãå»çãžã®ã¢ã¯ã»ã¹ã移æ°ã¹ããŒã¿ã¹ãã 圌ã¯æ¬¡ã®ããã«äž»åŒµããŠããŸãã
é«éœ¢è ãé害ã®ãã人ã¯ãæ¥åžžç掻ãæ¯æŽã·ã¹ãã ãæ··ä¹±ãããšç¹ã«å±éºã«ãããããŸãã 蟲æéšãå äœæ°æãªã©ãå»çãç°¡åã«å©çšã§ããªã人ã ã¯ãå¿ èŠãªãšãã«é·è·é¢ã移åããå¿ èŠã«çŽé¢ããå¯èœæ§ããããŸãã ãã§ã«ã¯ã·ã³ãã³å·ã§èŠãããããã«ãå ¬å¶äœå® ãè人ããŒã ãååæãé¿é£æïŒãããã¯è·¯äžã®ããŒã ã¬ã¹ïŒãªã©ã窮å±ãªç°å¢ã§æ®ãã人ã ã¯æ³¢ã«èŠèãããå¯èœæ§ãããã ãããŠãç¡çµŠåŽåè ãäžå®å®ãªå€åã¹ã±ãžã¥ãŒã«ãªã©ãäœè³éçµæžã®è匱ãªéšåãããã®å±æ©ã®éã«ãã¹ãŠã®äººã®ç®ã«ãããããããšã«ãªãã§ãããã æ絊ã§çµŠæãããã£ãŠããç±³åœã®åŽåè ã® 60 ããŒã»ã³ãã«ãå¿ èŠãªãšãã«ä»äºããé¢ããã®ãã©ãã»ã©ç°¡åããå°ããŠãã ããã
ç±³åœåŽåçµ±èšå±ã¯æ¬¡ã®ããšã瀺ããŠããŸãã
7. ç±³åœã«äœãç§ãã¡ã«ã¯ååãªæ å ±ããããŸããã
ç±³åœã«ããã倧ããªåé¡ã®äžã€ã¯ãã³ãããŠã€ã«ã¹ã®æ€æ»ãã»ãšãã©è¡ãããŠããããæ€æ»çµæãé©åã«å
±æãããŠããããå®éã«äœãèµ·ãã£ãŠããã®ãããåãããªãããšã ã å
FDAé·å®ã®ã¹ã³ããã»ãŽãããªãŒãæ°ã¯ãã·ã¢ãã«ã§ã¯æ€æ»ãå
å®ããŠããããããã·ã¢ãã«ã§ææè
ãçºçããŠããçç±ã ãšèª¬æããããã·ã¢ãã«ã§æ©ã段éã§æ°åã³ãããŠã€ã«ã¹ææçã®çºçã«ã€ããŠèããã®ã¯ãè¡çç«åŠç£èŠ[ã»ã³ããã«ç£èŠ]ã®æŽ»åã«ãããã®ã ã£ãã ]ç¬ç«ããç§åŠè
ã®ã ãã®ãããªç£èŠã¯ä»ã®éœåžã§ã¯ããã»ã©ã®èŠæš¡ã§å®æœãããããšã¯ãªãã ãããã£ãŠãç±³åœã®ä»ã®ãããã¹ãããã¯ãŸã å®å
šã«ã¯çºèŠãããŠããªãå¯èœæ§ããããŸããã ã¡ãã»ãŒãžã«ãããš
ç§ãã¡ãåéãã蚌æ ã¯ãæ°åã³ãããŠã€ã«ã¹ãšãããåŒãèµ·ããç æ°ã«å¯Ÿããç±³åœã®å¯Ÿå¿ããç¹ã«ä»ã®å é²åœãšæ¯ã¹ãŠæ¥µããŠç·©ãããšã瀺åããŠããã 19æ¥åãçŸç 管çäºé²ã»ã³ã¿ãŒïŒCDCïŒã¯ããã®ãŠã€ã«ã¹ãç±³åœã®äººã ã®éã§åºãã£ãŠããããšãã€ãŸãæµ·å€æ è¡ãããããšã®ãªãç±³åœäººãæµ·å€æž¡èªè ãšæ¥è§Šããããšã®ãªãç±³åœäººã«ãææããŠããããšã確èªããã éåœã§ã¯æåã®ææè ãåºãŠãã66é±é以å ã«650äž10人以äžãæ€æ»ãåããããã«000æ¥ãããXNUMXäžäººã®æ€æ»ãå¯èœã«ãªã£ãã
åé¡ã®äžéšã¯ããããæ¿æ²»åé¡ã«ãªã£ãŠãããšããããšã ã ããã«ãã»ãã©ã³ã倧統é ã¯ãç±³åœã®ææè
æ°ãäœãæããããšã®èããæããã«ããã ããã¯ãã¡ããªã¯ã¹ã®æé©åãå®éã«è¯å¥œãªçµæãåŸãäžã§ã©ã®ããã«åŠšãããããã瀺ãäŸã§ã (ãã®åé¡ã«ã€ããŠã¯ãããŒã¿ ãµã€ãšã³ã¹ã®å«çã«é¢ããèšäºã§è©³ãã説æãããŠããŸã)ã
äžçä¿å¥æ©é¢ (WHO) ã«å€åããŠãããšããäžçã HIV/AIDS ãã³ãããã¯ã«å¯ŸåŠã§ããããæ¯æŽããããã«åµèšãããäžçãšã€ãºèšç» (çŸåšã® UNAIDS) ã«æºãã£ãŠããŸããã ãã®å±æ©ã®å æãæ¯æŽããããšã«å°å¿µããç®èº«çãªå»åž«ãç§åŠè ãããŸããã å±æ©çºçæã«ã¯ãïŒåœãå·ãå°æ¹ãäŒæ¥ãéå¶å©å£äœãåŠæ ¡ã家æãå人ãªã©ã®ããããã¬ãã«ã§ïŒå¯Ÿå¿æ¹æ³ã«ã€ããŠååãªæ å ±ã«åºã¥ããææ決å®ãè¡ãããã«ãæ確ã§ä¿¡é Œã§ããæ å ±ãéèŠã§ãã é©åãªæ å ±ã«ã¢ã¯ã»ã¹ããæé«ã®å»åŠçããã³ç§åŠçå°é家ããã®ã¢ããã€ã¹ãããã°ãHIV/AIDS ã§ãããæ°åã³ãããŠã€ã«ã¹ææç (COVID-19) ã§ãããç§ãã¡ã¯èª²é¡ãå æããããšãã§ããŸãã ããããæ¿æ²»çå©çã«ãã£ãŠåããããåœæ å ±ã®å Žåãæ¡å€§ãããã³ãããã¯ã«çŽé¢ããŠè¿ éãã€æåºãšããè¡åããšããããããç æ°ã®ããéãè延ã«ç©æ¥µçã«è²¢ç®ããå Žåãç¶æ³ãæ·±å»ã«æªåããã倧ããªãªã¹ã¯ããããŸãã ä»ããã®ãããªããšãèµ·ããŠããã®ãèŠãã®ã¯ãšãŠãèŸãããšã§ãã
æ°åã³ãããŠã€ã«ã¹ææçã«é¢ããéææ§ãéèŠããæ¿æ²»å¢åã¯ãªãããã ã ã¢ã¬ãã¯ã¹ã»ã¢ã¶ãŒä¿å¥çŠç¥é·å®ã
ãããšãã©ã³ãæ°ã¯ã¢ã¶ãŒã«æ°ã®è©±ãé®ã£ãã ãéèŠãªããšã¯ãæ€æ»ãå¿ èŠãªäººã¯èª°ã§ãæ€æ»ãåããããšã ãšæããŸãã ãã¹ãã¯ãããŸãããããã¯è¯ãããšã§ãã æ€æ»ãå¿ èŠãªäººã¯å šå¡æ€æ»ãåããããšãã©ã³ã倧統é ã¯èªã£ãã ããã¯æ¬åœã§ã¯ãªãã ãã³ã¹å¯å€§çµ±é ã¯æšææ¥ãèšè å£ã«å¯Ÿããç±³åœã«ã¯éèŠãæºããã®ã«ååãªæ°åã³ãããŠã€ã«ã¹æ€æ»ããªããšèªã£ãã
ä»ã®åœã
ã¯ç±³åœãããã¯ããã«æ©ãåå¿ããŠããŸãã æ±åã¢ãžã¢ã®å€ãã®åœã¯ãŠã€ã«ã¹ã®å°ã蟌ãã«ããŸãåãçµãã§ããŸãã ããšãã°ãR0 ã 0.3 ã«äœäžããå°æ¹Ÿããäžè¬ã«ã·ã³ã¬ããŒã«
8ã çµè«
æ°åã³ãããŠã€ã«ã¹ææçã¯éèŠãªç€ŸäŒåé¡ã§ãããç§ãã¡å šå¡ãç æ°ã®è延ãæããããã«ããããåªåãããããšãã§ããã ãã§ãªããããããªããã°ãªããŸããã ãã®ããã«ïŒ
- 倧èŠæš¡ãªã€ãã³ããæ··éãé¿ããïŒç€ŸäŒçè·é¢ãä¿ã€ïŒ
- æåã€ãã³ãããã®ä»ã®å ¬å ±ã€ãã³ããäžæ¢ãã
- å¯èœãªéãåšå® å€å
- åž°å® æãå€åºæãªã©å®¶ã®å€ã§éãããšãã¯æãæŽããŸããã
- ç¹ã«å€åºæã¯é¡ã«è§Šããªãããã«ããŸããã
泚: ãã®æçš¿ãã§ããã ãæ©ãå ¬éããå¿ èŠããããããä¿¡é Œããæ å ±æºã®åŒçšã«ã¯éåžžãããå°ãæ éããæ¬ ããŠããŸãã äœãèŠéããå Žåã¯ãç¥ãããã ããã
貎éãªãã£ãŒãããã¯ãæäŸããŠããã Sylvain Gugger ãš Alexis Gallagher ã«æè¬ããŸãã
åèïŒ
1 ç«åŠè ã¯ç æ°ã®è延ãç 究ãã人ã ã§ãã æ»äº¡çã R0 ãªã©ã®æšå®ã¯å®éã«ã¯éåžžã«é£ããããšãå€æããŸããããã®ããããããå°éãšããåéå šäœãååšããŸãã åçŽãªæ¯çãçµ±èšã䜿ã£ãŠ covid-19 ã®åœ±é¿ãäŒãã人ã«ã¯æ³šæããŠãã ããã 代ããã«ãç«åŠè ã«ãã£ãŠè¡ãããã¢ããªã³ã°ãèŠãŠãã ããã
2 ããã¯æè¡çã«ééã£ãŠããŸãã å³å¯ã«èšãã°ãR0 ã¯åå¿ããªãå Žåã®ææçãæããŸãã ããããããã¯ç§ãã¡ãå®éã«æ°ã«ããŠããããšã§ã¯ãªãã®ã§ãå®çŸ©ãå°ããããã«ãªãããšãèš±å¯ããŸãã
3 ãã®æ±ºå®ä»¥æ¥ãç§ãã¡ã¯å¯Ÿé¢ããŒãžã§ã³ãããããã«åªããããŒãã£ã« ã³ãŒã¹ãéå§ããæ¹æ³ãèŠã€ããããã«æžåœã«åãçµãã§ããŸããã ç§ãã¡ã¯ãããäžçäžã®ãã¹ãŠã®äººã«å ¬éããããšãã§ããä»®æ³åŠç¿ã°ã«ãŒãããããžã§ã¯ã ã°ã«ãŒããšæ¯æ¥ååããŠãããŸãã
4 ãŸãããžã ã«è¡ããã«èªå® ã§éåããããã¹ãŠã®äŒè°ããããªäŒè°ã«çœ®ãæããã楜ãã¿ã«ããŠããå€ã®æŽ»åãã¹ããããããªã©ãã©ã€ãã¹ã¿ã€ã«ã«å€ãã®å°ããªå€æŽãå ããŸããã
A. OgurtsovãYu. KashnitskyãT. Gabruseva ã翻蚳ã«åãçµã¿ãŸããã
åºæïŒ habr.com